230 related articles for article (PubMed ID: 24195978)
21. Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: a cross-sectional study.
Gupta E; Kumar A; Choudhary A; Kumar M; Sarin SK
Indian J Med Microbiol; 2012; 30(2):150-4. PubMed ID: 22664428
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics and Correlation Analysis of Subjects with Chronic Hepatitis B Virus (HBV) Infection and Sustained Low Levels of Hepatitis B Surface Antigen (HBsAg).
Cheng J; Dai Y; Yan L; Zhou H; Xu X; Sun C; Wang Z
Med Sci Monit; 2018 Mar; 24():1826-1835. PubMed ID: 29593208
[TBL] [Abstract][Full Text] [Related]
23. Can hepatitis B virus DNA in semen be predicted by serum levels of hepatitis B virus DNA, HBeAg, and HBsAg in chronically infected men from infertile couples?
Fei QJ; Yang XD; Ni WH; Pan CS; Huang XF
Andrology; 2015 May; 3(3):506-11. PubMed ID: 25873521
[TBL] [Abstract][Full Text] [Related]
24. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
Sonneveld MJ; Rijckborst V; Cakaloglu Y; Simon K; Heathcote EJ; Tabak F; Mach T; Boucher CA; Hansen BE; Zeuzem S; Janssen HL
Antivir Ther; 2012; 17(1):9-17. PubMed ID: 22267464
[TBL] [Abstract][Full Text] [Related]
25. The correlation between serum HBsAg levels and viral loads depends upon wild-type and mutated HBV sequences rather than the HBeAg/anti-HBe status.
Liu MH; Chen QY; Harrison TJ; Li GJ; Li H; Wang XY; Ju Y; Yang JY; Fang ZL
J Med Virol; 2015 Aug; 87(8):1351-60. PubMed ID: 25879734
[TBL] [Abstract][Full Text] [Related]
26. Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?
Sali S; Sharafi H; Alavian SH; Alavian SM; Etesam F; Salimi S; Merza MA; Keshvari M
Diagn Microbiol Infect Dis; 2015 Jun; 82(2):114-9. PubMed ID: 25863529
[TBL] [Abstract][Full Text] [Related]
27. Mutations in reverse transcriptase region of HBV affect Hepatitis B surface antigen titers and its correlation with HBV DNA.
Shen H; Chen C; Ye C; Zhang H; Hang S; Chen M; Zhu Z; Xue Y; Liu L
J Infect Dev Ctries; 2019 Nov; 13(11):1062-1067. PubMed ID: 32087080
[TBL] [Abstract][Full Text] [Related]
28. Correlation between hepatitis B virus DNA levels and diagnostic tests for HBsAg, HBeAg, and PreS1-Ag in chronic hepatitis B.
Liu X; Chen JM; Lou JL; Huang YX; Yan Y; Sun GZ; Li N
Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421011
[TBL] [Abstract][Full Text] [Related]
29. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy.
Chen J; Wang Z; Zhou B; Wang Y; Hou J
Antivir Ther; 2012; 17(1):71-9. PubMed ID: 22267471
[TBL] [Abstract][Full Text] [Related]
31. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
[TBL] [Abstract][Full Text] [Related]
33. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.
Tseng TC; Liu CJ; Su TH; Wang CC; Chen CL; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2011 Aug; 141(2):517-25, 525.e1-2. PubMed ID: 21672542
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection.
Tan Z; Li M; Kuang X; Tang Y; Fan Y; Deng G; Wang Y; He D
J Clin Virol; 2014 Apr; 59(4):228-34. PubMed ID: 24529415
[TBL] [Abstract][Full Text] [Related]
35. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women.
Sun KX; Li J; Zhu FC; Liu JX; Li RC; Zhai XJ; Li YP; Chang ZJ; Nie JJ; Zhuang H
Vaccine; 2012 Aug; 30(36):5335-40. PubMed ID: 22749833
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.
Madejón A; Romero M; Hernández Á; García-Sánchez A; Sánchez-Carrillo M; Olveira A; García-Samaniego J
World J Gastroenterol; 2016 Mar; 22(11):3165-74. PubMed ID: 27003993
[TBL] [Abstract][Full Text] [Related]
37. Are serum quantitative hepatitis b surface antigen levels, liver histopathology and viral loads related in chronic hepatitis b-infected patients?
Balkan A; Namiduru M; Balkan Y; Mete AO; Karaoglan I; Bosnak VK
Saudi J Gastroenterol; 2016; 22(3):208-14. PubMed ID: 27184639
[TBL] [Abstract][Full Text] [Related]
38. Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E.
Boglione L; Cardellino CS; De Nicolò A; Cariti G; Di Perri G; D'Avolio A
J Med Virol; 2014 Nov; 86(11):1845-50. PubMed ID: 25131947
[TBL] [Abstract][Full Text] [Related]
39. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Hsu CA; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
Hepatology; 2013 Feb; 57(2):441-50. PubMed ID: 22941922
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
Jaroszewicz J; Calle Serrano B; Wursthorn K; Deterding K; Schlue J; Raupach R; Flisiak R; Bock CT; Manns MP; Wedemeyer H; Cornberg M
J Hepatol; 2010 Apr; 52(4):514-22. PubMed ID: 20207438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
